| Term | Count | % |
|---|---|---|
| OCULAR HYPERAEMIA | 456 | 9.69% |
| EYE IRRITATION | 402 | 8.54% |
| EYE PAIN | 268 | 5.69% |
| EYE PRURITUS | 225 | 4.78% |
| DRUG INEFFECTIVE | 200 | 4.25% |
| DEATH | 195 | 4.14% |
| VISION BLURRED | 159 | 3.38% |
| HEADACHE | 155 | 3.29% |
| EYE SWELLING | 118 | 2.51% |
| DRY EYE | 105 | 2.23% |
| INTRAOCULAR PRESSURE INCREASED | 94 | 2.00% |
| PHOTOPHOBIA | 75 | 1.59% |
| LACRIMATION INCREASED | 71 | 1.51% |
| DIZZINESS | 67 | 1.42% |
| DYSPNOEA | 67 | 1.42% |
| HYPERSENSITIVITY | 64 | 1.36% |
| OFF LABEL USE | 60 | 1.27% |
| FATIGUE | 55 | 1.17% |
| PRURITUS | 54 | 1.15% |
| COUGH | 51 | 1.08% |
| VISUAL IMPAIRMENT | 48 | 1.02% |
| PAIN | 44 | 0.93% |
| NAUSEA | 43 | 0.91% |
| RASH | 41 | 0.87% |
| URINARY TRACT INFECTION | 40 | 0.85% |
| EYE DISCHARGE | 39 | 0.83% |
| ERYTHEMA | 37 | 0.79% |
| GLAUCOMA | 36 | 0.76% |
| FOREIGN BODY SENSATION IN EYES | 35 | 0.74% |
| PRODUCT QUALITY ISSUE | 35 | 0.74% |
| PRODUCT DOSE OMISSION ISSUE | 34 | 0.72% |
| DIARRHOEA | 33 | 0.70% |
| NO ADVERSE EVENT | 31 | 0.66% |
| OCULAR DISCOMFORT | 31 | 0.66% |
| ARTHRALGIA | 30 | 0.64% |
| FALL | 30 | 0.64% |
| NASOPHARYNGITIS | 28 | 0.59% |
| DRUG HYPERSENSITIVITY | 27 | 0.57% |
| ERYTHEMA OF EYELID | 27 | 0.57% |
| CEREBROVASCULAR ACCIDENT | 26 | 0.55% |
| VISUAL ACUITY REDUCED | 26 | 0.55% |
| ALOPECIA | 25 | 0.53% |
| BLOOD PRESSURE INCREASED | 25 | 0.53% |
| DRUG DOSE OMISSION | 25 | 0.53% |
| CATARACT | 24 | 0.51% |
| EYE INFLAMMATION | 24 | 0.51% |
| MALAISE | 24 | 0.51% |
| DYSPHONIA | 23 | 0.49% |
| RHINORRHOEA | 23 | 0.49% |
| SYNCOPE | 23 | 0.49% |
| BLEPHARITIS | 22 | 0.47% |
| INSOMNIA | 22 | 0.47% |
| EYELID IRRITATION | 21 | 0.45% |
| HYPERTENSION | 21 | 0.45% |
| OROPHARYNGEAL PAIN | 21 | 0.45% |
| WRONG TECHNIQUE IN PRODUCT USAGE PROCESS | 21 | 0.45% |
| ABNORMAL SENSATION IN EYE | 20 | 0.42% |
| ASTHENIA | 20 | 0.42% |
| CONSTIPATION | 20 | 0.42% |
| COVID-19 | 19 | 0.40% |
| DRUG INTERACTION | 19 | 0.40% |
| DRY MOUTH | 19 | 0.40% |
| BURNING SENSATION | 18 | 0.38% |
| MUSCULAR WEAKNESS | 18 | 0.38% |
| MYOCARDIAL INFARCTION | 18 | 0.38% |
| SKIN DISCOLOURATION | 18 | 0.38% |
| SKIN EXFOLIATION | 18 | 0.38% |
| BLINDNESS | 17 | 0.36% |
| EYELID OEDEMA | 17 | 0.36% |
| EYELIDS PRURITUS | 17 | 0.36% |
| PNEUMONIA | 17 | 0.36% |
| SWELLING OF EYELID | 17 | 0.36% |
| TREATMENT FAILURE | 17 | 0.36% |
| ARRHYTHMIA | 16 | 0.34% |
| CHEST DISCOMFORT | 16 | 0.34% |
| PAIN IN EXTREMITY | 16 | 0.34% |
| PARAESTHESIA | 16 | 0.34% |
| SWELLING FACE | 16 | 0.34% |
| ABDOMINAL DISCOMFORT | 15 | 0.32% |
| BACK PAIN | 15 | 0.32% |
| DYSGEUSIA | 15 | 0.32% |
| HALLUCINATION | 15 | 0.32% |
| OVERDOSE | 15 | 0.32% |
| PALPITATIONS | 15 | 0.32% |
| PEMPHIGOID | 15 | 0.32% |
| PRODUCT USE ISSUE | 15 | 0.32% |
| SOMNOLENCE | 15 | 0.32% |
| DRY SKIN | 14 | 0.30% |
| EYE HAEMORRHAGE | 14 | 0.30% |
| EYELID MARGIN CRUSTING | 14 | 0.30% |
| MUSCLE SPASMS | 14 | 0.30% |
| PERIPHERAL SWELLING | 14 | 0.30% |
| THROAT IRRITATION | 14 | 0.30% |
| URTICARIA | 14 | 0.30% |
| WEIGHT DECREASED | 14 | 0.30% |
| ABDOMINAL PAIN UPPER | 13 | 0.28% |
| ANAEMIA | 13 | 0.28% |
| ATRIAL FIBRILLATION | 13 | 0.28% |
| BALANCE DISORDER | 13 | 0.28% |
| BLOOD GLUCOSE INCREASED | 13 | 0.28% |
| Total | 4707 |